Ashar Bhavesh (CIK 1849740) reported 3 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-05-07). Recent activity: Buy TYRA (15,013 shares), Sell SWTX (62,053 shares), Sell SWTX (1,016 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-07 | Tyra Biosciences, Inc. (TYRA) | Chief Operating Officer | Buy | 15,013 | $0 |
| 2025-07-02 | SpringWorks Therapeutics, Inc. (SWTX) | Chief Commercial Officer | Sell | 62,053 | $0 |
| 2025-02-24 | SpringWorks Therapeutics, Inc. (SWTX) | Chief Commercial Officer | Sell | 1,016 | $62,169 |
Source: SEC Form 4 filings · as of 2026-05-07